Deregulation of the CHN2 gene has been associated with human pathologies including mental disorders [16, 17], insulin resistance [18], and cancers such as glioblastoma, hepatosplenic T-cell lymphoma and breast cancer [19–21]. This evidence concerns the gene CHN2 and breast cancer.